Ariad's Harvey Berger has tried every imaginable way to boost the share price of Ariad over the last 6 months, and no one, and I mean no one believes in him as the share price clearly shows. There are a ton of new biotechs coming public now, with much brighter futures, with less toxic concerns. It will be extremely difficult for Ariad to capture investor money now with all the competition in the biotech space. I have seen this road before in the tech space.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.